UNSPSC 51162615: Clobutinol

This classification denotes an antitussive agent with the molecular formula C14H22ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 1NY2IX043A, chemically known as 1-(4-chlorophenyl)-2,3-dimethyl-4-dimethylamino-2-butanol but more generally known as clobutinol, which bears US NIH Compound Identifier 26937. European Medicines Agency schedules Clobutinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06680MIG.

UNSPSC 51162615 Clobutinol is a Commodity code that nominally identifies a single pharmaceutical product, but recent state and local opportunities tagged with this code do not reflect clobutinol procurement specifically. Instead, the code appears in solicitations for broader pharmaceutical and over-the-counter product procurement, including naloxone, drug deactivation systems, and generic multi-source pharmaceuticals. State and local issuing bodies using this code span county health departments and multistate cooperative purchasing alliances. Seminole County, Florida and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, have both recently posted solicitations under related pharmaceutical codes, reflecting health and safety priorities across county and state cooperative structures.

Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response due July 26, 2023. MMCAP issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, including Oregon, with proposals due March 26, 2026. The mismatch between the code's nominal scope (clobutinol, a specific pharmaceutical) and the actual work being bought (broader naloxone, drug deactivation, and generic pharmaceuticals) suggests this code shows limited relevance to current state and local procurement activity targeting clobutinol specifically. Activity documented here reflects wider health-system and emergency-response pharmaceutical sourcing rather than procurement of the coded product itself.